ATE452144T1 - Verfahren zur herstellung von humaneigenblutzytokinen - Google Patents

Verfahren zur herstellung von humaneigenblutzytokinen

Info

Publication number
ATE452144T1
ATE452144T1 AT98955520T AT98955520T ATE452144T1 AT E452144 T1 ATE452144 T1 AT E452144T1 AT 98955520 T AT98955520 T AT 98955520T AT 98955520 T AT98955520 T AT 98955520T AT E452144 T1 ATE452144 T1 AT E452144T1
Authority
AT
Austria
Prior art keywords
aliquot
human blood
cells
producing human
donor
Prior art date
Application number
AT98955520T
Other languages
English (en)
Inventor
Nikolaus W Klehr
Original Assignee
Nikolaus W Klehr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikolaus W Klehr filed Critical Nikolaus W Klehr
Priority claimed from PCT/EP1998/006757 external-priority patent/WO1999021887A2/de
Application granted granted Critical
Publication of ATE452144T1 publication Critical patent/ATE452144T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT98955520T 1997-10-23 1998-10-23 Verfahren zur herstellung von humaneigenblutzytokinen ATE452144T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19746865 1997-10-23
DE19821843A DE19821843A1 (de) 1997-10-23 1998-05-15 Verfahren zur Herstellung von Humaneigenblutzytokinen
PCT/EP1998/006757 WO1999021887A2 (de) 1997-10-23 1998-10-23 Verfahren zur herstellung von humaneigenblutzytokinen

Publications (1)

Publication Number Publication Date
ATE452144T1 true ATE452144T1 (de) 2010-01-15

Family

ID=7846417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98955520T ATE452144T1 (de) 1997-10-23 1998-10-23 Verfahren zur herstellung von humaneigenblutzytokinen

Country Status (2)

Country Link
AT (1) ATE452144T1 (de)
DE (2) DE19821843A1 (de)

Also Published As

Publication number Publication date
DE59814423D1 (de) 2010-01-28
DE19821843A1 (de) 1999-04-29

Similar Documents

Publication Publication Date Title
DE68923805T2 (de) Verfahren zur herstellung von optisch aktivem 1,3-butanediol.
DE69126430D1 (de) Ligand für das neu-gen-produkt
ATE268353T1 (de) Verfahren zur herstellung von mit antioxidant gedoptem uhmwpe und daraus hergestelltes implantat
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
ATE358493T1 (de) Menschliche mesenchymale stammzellen aus peripherem blut
ATE343396T1 (de) Immunverstärkende zusammensetzung in fester verabreichungsform mit kollagen oder polydimethylsiloxan als trägersubstanzen
DE3773963D1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
FR2491334B1 (de)
DE69001573T2 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
DE68908223D1 (de) Verfahren zur herstellung von sehr reiner, dichter grossteiliger kieselsaeure.
DE3888523D1 (de) Verfahren zur herstellung von 4,4'-dibromdiphenylether.
ATE190061T1 (de) Verfahren zur herstellung von alkoxysilanen
DE3783199D1 (de) Verfahren zur herstellung von 4,4' diaminodiphenylmethan und derivaten davon.
ATE452144T1 (de) Verfahren zur herstellung von humaneigenblutzytokinen
DE69013429T2 (de) Verfahren zur Herstellung von 2,2-Dimethyl-3-hydroxypropyl-2,2-dimethyl-3-hydroxypropionat.
NO965087L (no) Isolert nukleinsyremolekyl som koder for en tumorrejeksjonsantigenforlöper, og anvendelse derav
DE3781425D1 (de) Verfahren zur herstellung von alpha,beta-ungesaettigten aldehyden.
DE3860105D1 (de) Verfahren zur herstellung von 4,4'-dichlordiphenylsulfonen.
IT1198233B (it) Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
DE3779247D1 (de) Verfahren zur herstellung von 2,3,5-trimethylhydrochinon.
DE68917379D1 (de) Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind.
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
ES2061731T3 (es) Procedimiento de extraccion de antigenos de membrana con propiedades inmunogenicas de celulas neoplasicas humanas y los productos asi obtenidos.
DE3781254D1 (de) Verfahren zur herstellung von eiweisshydrolysaten, loeslich in einem saeuremilieu und die erhaltenen hydrolysate.
DE3770059D1 (de) Verfahren zur herstellung von 4,4'-bis-phenol.